2024-12-20 - Analysis Report
## Intuitive Surgical Inc. (ISRG) Stock Analysis Report

**1. Performance Comparison and Outperformance:**

Intuitive Surgical Inc. (ISRG) is a company that develops, manufactures, and markets the da Vinci surgical system and related instruments and accessories.  The cumulative return of ISRG is 284.46%, significantly outperforming the S&P 500 (VOO) with a cumulative return of 114.28%. The difference is 170.2%, placing it at the 90.6th percentile of its historical performance relative to the S&P 500.  This indicates a substantial outperformance over the period considered.  The provided alpha values of 0.0 suggest that the outperformance cannot be solely explained by market beta (systematic risk), implying a skillful management and significant company specific factors have contributed.

**2. Recent Price Movement:**

* **Closing Price:** $523.91
* **5-Day Moving Average:** $535.42
* **20-Day Moving Average:** $541.63
* **60-Day Moving Average:** $518.00

The stock price is currently below its 5-day and 20-day moving averages, suggesting a recent downward trend. However, it's above its 60-day moving average, indicating potential support.


**3. Technical Indicators and Expected Return:**

* **RSI:** 36.34 (below 50, suggesting oversold conditions)
* **PPO:** -0.62 (negative, indicating bearish momentum)
* **20-Day Relative Divergence:** -4.4% (short-term downward trend)
* **Expected Return (vs. S&P 500):** 112.4% over the long term (2+ years)

The technical indicators point towards a bearish short-term outlook.  However, the high expected return relative to the S&P 500 suggests potential for long-term growth, provided the current market conditions and company performance are maintained. The current price of $523.91, being below the moving averages, does not suggest a significant recent sudden change (no sharp upturn or downturn).


**4. Recent Earnings Analysis:**

The provided earnings data shows a generally increasing trend in both revenue and EPS, although there is some fluctuation between quarters.

* **Revenue Growth:** Revenue has generally increased quarter-over-quarter, except for a slight dip between Q2 2024 and Q1 2024.
* **EPS Trends:** EPS shows a similar trend to revenue, increasing overall, but with fluctuations between quarters.  There is no significant change from one quarter to the next.  For example there's a small decrease in EPS from Q2 2024 to Q3 2024.  The earnings data is also inconsistent with a duplicate entry for October 18th, 2024.
* **Comparison to Expectations:**  Without access to expected earnings, it's impossible to determine whether the reported numbers represent beats or misses.

**5. Financial Information Analysis:**

* **Revenue and Profitability:** Revenue shows consistent growth (with minor fluctuations). Profit margins remain relatively high and stable, hovering around 66-68%.
* **Capital and Profitability:** Equity is steadily increasing, reflecting company growth. ROE fluctuates, suggesting varying returns on investment across quarters.

**6. News and Recent Issues:**

This section requires access to real-time news sources to provide information on recent earnings news (within the last two days), market outlook, and analyst opinions.  This information is not provided in the initial prompt.

**7. Overall Analysis:**

ISRG has shown strong historical performance significantly outperforming the S&P 500. While short-term indicators suggest a bearish trend, the long-term outlook remains positive, supported by consistent revenue growth, relatively high profit margins, and a strong expected return compared to the benchmark.  However, the short-term price decline and mixed signals from technical indicators warrant caution. More information on recent news, market outlook, and analyst opinions is crucial for a complete and updated assessment.  Further investigation into the inconsistent earnings data from October 18th, 2024 is also needed.

**8. Recommendations:**

A thorough due diligence is needed before investing in ISRG.  Considering the long-term positive outlook but short-term uncertainties, a cautious approach with a longer-term investment horizon (2+ years) might be appropriate for risk-tolerant investors. However, monitoring the market outlook, analyst opinions, and news concerning the company's performance is crucial.  Clarification of the duplicated data points in the earnings analysis is also essential for accurate assessment.
